1. Home
  2. BROS vs BLCO Comparison

BROS vs BLCO Comparison

Compare BROS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BROS
  • BLCO
  • Stock Information
  • Founded
  • BROS 1992
  • BLCO 1853
  • Country
  • BROS United States
  • BLCO Canada
  • Employees
  • BROS N/A
  • BLCO N/A
  • Industry
  • BROS Restaurants
  • BLCO Ophthalmic Goods
  • Sector
  • BROS Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • BROS Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • BROS 7.0B
  • BLCO 6.3B
  • IPO Year
  • BROS 2021
  • BLCO 2022
  • Fundamental
  • Price
  • BROS $64.66
  • BLCO $17.50
  • Analyst Decision
  • BROS Strong Buy
  • BLCO Buy
  • Analyst Count
  • BROS 11
  • BLCO 12
  • Target Price
  • BROS $60.09
  • BLCO $20.55
  • AVG Volume (30 Days)
  • BROS 2.3M
  • BLCO 558.2K
  • Earning Date
  • BROS 02-12-2025
  • BLCO 02-19-2025
  • Dividend Yield
  • BROS N/A
  • BLCO N/A
  • EPS Growth
  • BROS 711.34
  • BLCO N/A
  • EPS
  • BROS 0.32
  • BLCO N/A
  • Revenue
  • BROS $1,192,352,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • BROS $32.74
  • BLCO $17.32
  • Revenue Next Year
  • BROS $21.61
  • BLCO $5.98
  • P/E Ratio
  • BROS $200.31
  • BLCO N/A
  • Revenue Growth
  • BROS 30.53
  • BLCO 18.01
  • 52 Week Low
  • BROS $25.46
  • BLCO $13.16
  • 52 Week High
  • BROS $64.90
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • BROS 70.80
  • BLCO 46.36
  • Support Level
  • BROS $60.06
  • BLCO $16.99
  • Resistance Level
  • BROS $63.98
  • BLCO $18.14
  • Average True Range (ATR)
  • BROS 2.04
  • BLCO 0.49
  • MACD
  • BROS 0.21
  • BLCO 0.09
  • Stochastic Oscillator
  • BROS 96.36
  • BLCO 54.75

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments company-operated shops and franchising and other.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: